TFAP2B Antibody, Biotin conjugated

1. Data suggest that expression of TFAP2B in lobular carcinoma in situ and invasive lobular breast cancer is up-regulated as compared to control mammary gland epithelium; TFAP2B appear to be involved in regulation of cell proliferation in these slow-growing breast cancer subtypes. PMID: 29035379
2. previously, only 10 different pathogenic variants in the TFAP2B gene have been associated with the Char syndrome and patent ductus arteriosus (human gene mutation database subscription). We have thus identified the 11th mutation, namely, c.851T>C, p. Leu284Ser, which cosegregates with the phenotype. PMID: 29683802
3. study demonstrates that AP-2beta promotes tumor growth and predicts poor prognosis, and may represent a potential therapeutic target for breast cancer. PMID: 29972820
4. Reduced TFAP2B expression in EC was significantly associated with high grade (OR=2.2 for well, moderate vs. poor), stage (OR=2.5 for I vs. IV), histology (OR=1.8 for serous vs. endometrioid), distant metastasis (OR=2.4 for positive vs. negative) (all p-values<0.05). PMID: 29602546
5. TFAP2B mutation is associated with tooth abnormalities. PMID: 28381879
6. AP-2 beta and beta-catenin interact both in vitro through GST pull-down assays and in vivo by co-immunoprecipitation. We further identified the interaction regions to the DNA-binding domain of AP-2 beta and the 1-9 Armadillo repeats of beta-catenin. PMID: 28277615
7. Single nucleotide polymorphisms (SNP) in angiotensin II receptor, type 1 (AGTR1), transcription factor AP-2 beta (TFAP2B), and tumor necrosis factor receptor-associated factor 1 (TRAF1) have been reported to be associated with the incidence of PDA in preterm infants. PMID: 26615960
8. results suggest that TFAP2B is playing a vital role in retaining retinoic acid responsiveness and mediating noradrenergic neuronal differentiation in neuroblastoma. PMID: 26598443
9. The presence of the nine-repeat variant of the TFAP-2beta intron 1 VNTR appears to protect girls with ADHD symptoms from the co-expression of symptoms of depression. PMID: 23824473
10. The expression of TFAP-2beta mRNA in tissue of patients with endometrial carcinoma was higher than that of normal endometrium. The expression of TFAP-2beta mRNA in endometrial tissue of patients with metabolism syndrome was higher than that of lean ones. PMID: 26189251
11. TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling. PMID: 24766673
12. The AP-2beta polymorphism significantly influenced cognitive performance, whereas the MAOA and COMT polymorphisms did not. PMID: 23881096
13. A haploinsufficiency effect of TFAP2B could be involved in familial isolated patent ductus arteriosus. PMID: 24507797
14. TFAP2B rs987237 and dietary protein/carbohydrate interacted to modify weight maintenance. PMID: 24081236
15. genomic GATA4 and TFAP2B missense mutations may be associated with nonfamilial congenital heart disease with diverse clinical phenotypes in patients with congenital heart disease from southern China PMID: 22959235
16. Under energy restriction, TFAP2B may modify the effect of dietary fat intake on weight loss and waist reduction PMID: 22952648
17. The findings suggest the lack of involvement of known mutations of TFAP2B with syndromic or nonsyndromic CHDs in Mysore patients PMID: 22199100
18. TFAP2B mutation should be considered a risk factor for isolated PDA. However, the detailed genetic mechanism underlying nonsyndromic the PDA-causing TFAP2B mutation is yet to be elucidated. PMID: 21643846
19. This study supports a role of the SLC6A4, DRD4 and TFAP2B genes in the temperament, including a gene-gene interaction between SLC6A4 and TFAP2B. It also provides evidence about an effect of the TFAP2B polymorphism in TFAP2B gene transcription. PMID: 21504541
20. A novel splice-junction in TFAP-2B gene might lead to hereditary patent ductus arteriosus in a Chinese family. PMID: 21215182
21. central obesity-associated variants in LYPLAL1, NRXN3, MSRA, and TFAP2B PMID: 21674055
22. It causes accumulation of neutral fats and causes insulin resistance through exaggerated glucose uptake independent of insulin and induces abnormal adipokine secretion, fat cell enlargement and insulin resistance. PMID: 21766608
23. Loss of TFAP2B is associated with retinoblastoma. PMID: 20607706
24. TFAP2B seems to regulate the expression of various adipokines in vivo PMID: 20019683
25. The present study identifies TFAP2b as a suggestive candidate gene in alcohol dependence. PMID: 19778525
26. no association between a transcription factor Activating Protein 2beta (AP-2beta) gene variant and schizophrenia PMID: 12270648
27. AP-2beta intron 2 genotype is associated with low levels of anxiety-related personality traits in women. PMID: 14673213
28. No association between the AP-2beta genotype and measures of dopamine receptor density, or CSF 5-HIAA concentrations. PMID: 15057523
29. AP-2beta expression was observed in the low-stage subtypes of renal cell carcinoma, and this transcription factor may be related to early carcinogenesis. PMID: 15245963
30. No differences are observed in AP-2 beta genotype frequencies between 176 subjects with premenstrual dysphoric disorder (PMDD) and 91 healthy controls. PMID: 15722186
31. Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus. PMID: 15940393
32. TFAP2B may contribute to the pathogenesis of type 2 diabetes through regulation of adipocytokine gene expression, and that TFAP2B may be a promising target for treatment or prevention of this disease. PMID: 16373396
33. Boys and girls with the combination of presence of the short 5-HTTLPR, and homozygosity for the long AP-2beta genotype scored significantly lower on Self-Transcendence and Spiritual Acceptance. PMID: 17123722
34. Investigators speculate on the possible role of TFAP2B gene on the duplicated segment in the three reported cases of partial trisomy. PMID: 17185054
35. TFAP2B was validated as direct target gene mediating the anti-apoptotic function of PAX3/FKHR PMID: 17525748
36. L-PGDS gene expression in TE671 cells was activated by USF1 through the aE-box within intron 4 and cooperatively by AP-2beta in the promoter in a cell-type-specific manner. PMID: 17574780
37. a potential usefulness of AP-2beta polymorphisms in explaining or predicting central nervous diseases, drug effects and side effects. PMID: 18358611
38. Novel TFAP2B mutation in nonsyndromic patent ductus arteriosus is reported. PMID: 18752453
39. Reduction of TFAP2B expression could have a protective effect against future risk of complications associated with decreased insulin sensitivity and central adiposity, such as type 2 diabetes and coronary heart disease. PMID: 19325541
40. TFAP2B, LYPLAL1 and MSRA are associated with adiposity and fat distribution. PMID: 19557161
41. AP-2beta directly inhibits adiponectin gene expression by displacing NF-YA and binding to its promoter. PMID: 16954217
42. Novel TFAP2B mutations causing Char syndrome have a dominant-negative effect and provide a genotype-phenotype correlation. PMID: 11505339

Show More

Hide All

HGNC: 11743

OMIM: 169100

KEGG: hsa:7021

STRING: 9606.ENSP00000377265

UniGene: Hs.33102